FDA inspection

Nippon Sanso Matheson, Inc.: FDA inspection ending Sep 7, 2023

FDA inspection 1218574 · No Action Indicated (NAI) · Waverly, NE

Key facts

Inspection ID 1218574
Firm Nippon Sanso Matheson, Inc.
FEI number 1950212
Address 9920 Deer Park Rd
City Waverly
State NE
ZIP 68462
Country United States
Fiscal year 2023
Inspection end date Sep 7, 2023
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections